April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
December 4, 2023
The University of Cincinnati's Rowena Schwartz joined The Oncology Nursing Podcast to discuss what oncology nurses need to know about a class of drugs called antimetabolites.
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.
April 18, 2022
Yahoo! News featured University of Cincinnati research into the use of Optune devices that provide electrical field treatment to the brain as a treatment for glioblastomas.
November 9, 2022
WCPO featured the University of Cincinnati's Rifat Wahab in an article about racial disparities in breast cancer diagnoses and work being done to address the issue.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
November 7, 2022
MSN India highlighted recent research led by the University of Cincinnati's Trisha Wise-Draper about how immunotherapy and immunosuppression affects COVID-19 severity.
May 2, 2022
The University of Cincinnati's Alice Tang was featured in a Healio article discussing recently published research that administering an immunotherapy drug prior to surgery did not increase risks for patients with advanced oral cavity cancer.
May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.